Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer†

OBJECTIVES: Neoadjuvant therapy has emerged as a favoured treatment paradigm for patients with clinical N2 disease undergoing surgical resection for non-small-cell lung cancer. It is unclear whether such a treatment paradigm affects perioperative outcomes. We sought to examine the National Cancer Da...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Eur J Cardiothorac Surg
Auteurs principaux: Yendamuri, Sai, Groman, Adrienne, Miller, Austin, Demmy, Todd, Hennon, Mark, Dexter, Elisabeth, Picone, Anthony, Nwogu, Chukwumere, Dy, Grace K
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2018
Sujets:
Thoracic
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6018932/
https://ncbi.nlm.nih.gov/pubmed/29253122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ejcts/ezx406
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires